{"schema_version":"secwatch.filing_event.v1","accession":"0001554795-24-000039","form_type":"8-K","ticker":null,"cik":"0001118072","company_name":"SKINOVATION PHARMACEUTICAL INC","filed_at":"2024-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.438392+00:00","generated_at":"2026-06-05T04:33:46.593893+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Skinovation dismisses Pinnacle as auditor, engages Fruci & Associates","bullets":["Board dismissed Pinnacle Accountancy Group as independent auditor effective Jan 3, 2024.","Engaged Fruci & Associates as new independent registered public accounting firm same day.","Pinnacle's reports for fiscal years 2021 and 2022 contained no adverse opinion or qualification.","No disagreements with Pinnacle on accounting principles, disclosure, or audit scope.","Pinnacle provided a letter to SEC agreeing with the company's statements, filed as Exhibit 16.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001554795-24-000039","json":"https://secwatch.observer/filing/0001554795-24-000039.json","markdown":"https://secwatch.observer/filing/0001554795-24-000039.md","text":"https://secwatch.observer/filing/0001554795-24-000039.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1118072/000155479524000039/0001554795-24-000039-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1118072/000155479524000039/skin0301form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T04:33:46.593893+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4fe360284d75ba6dcea4d6ebebb44fbb986f0d9a","claim":"SKINOVATION PHARMACEUTICAL INC engaged Fruci & Associates as its auditor.","evidence_excerpt":"Also on January 3, 2024, the Company engaged the accounting firm of Fruci & Associates (“Fruci”) as the Company’s new independent registered public accounting firm.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1118072/000155479524000039/0001554795-24-000039-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"Fruci & Associates"}],"fact_type":"auditor_change"},{"claim_id":"8e588dd735b167704592fb22b205afcd9f103b0c","claim":"SKINOVATION PHARMACEUTICAL INC dismissed Pinnacle Accountancy Group of Utah as its auditor.","evidence_excerpt":"On January 3, 2024, the Board of Directors (the “Board”) of Skinovation Pharmaceutical Incorporated (“Skinovation” or the “Company) agreed to dismiss the Company’s independent registered public accounting firm, Pinnacle Accountancy Group of Utah (“Pinnacle”), effective as of January 3, 2024.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1118072/000155479524000039/0001554795-24-000039-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"dismissal"},{"label":"Auditor","value":"Pinnacle Accountancy Group of Utah"},{"label":"Successor","value":"Fruci & Associates"}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}